Trials / Unknown
UnknownNCT00772252
Oxidative Stress and Microcirculation in Patient With Hepatic Failure Undergoing Liver Support Treatment
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 80 (estimated)
- Sponsor
- National Taiwan University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Background: In patients undergoing hemodialysis or hemofiltration will suffer from the injury of reactive oxidative species. Oxidative stress will affect cell membrane, protein, and DNA. It will damage the cell and result in organ dysfunction. We believe that in patients, who have acute hepatic failure, undergoing plasma exchange or Molecular Absorbent Recirculating System for bridge therapy will suffer from the injury of reactive oxidative species, too. It will damage the kidney, lung, cerebral cortex, and other organs. It may result in death before the recovery of liver function or undergoing liver transplantation. Aims: 1. Investigate the severity of oxidative stress and risk factors of high oxidative stress in acute hepatic failure patient undergoing plasma exchange or Molecular Absorbent Recirculating System. 2. Investigate the microcirculation status and risk factors in acute hepatic failure patient undergoing plasma exchange or Molecular Absorbent Recirculating System. 3. Study the relationship between oxidative stress and microcirculation status. 4. Study the correlation between oxidative stress and prognosis. 5. Study the correlation between microcirculation status and prognosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | liver support treatment | plasma exchange for liver support treatment |
Timeline
- Start date
- 2008-08-01
- Primary completion
- 2010-07-01
- Completion
- 2010-12-01
- First posted
- 2008-10-15
- Last updated
- 2010-06-29
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT00772252. Inclusion in this directory is not an endorsement.